Vimarsana
Biggest News Aggregation in the World

Page 12 - Altimmune News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Altimmune. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Altimmune Today - Breaking & Trending Today

Nasal vaccines for COVID-19 offer hope and face hurdles - Vimarsana News

Nasal vaccines for COVID-19 offer hope and face hurdles

A squirt up the nose could reduce coronavirus transmission, but the vaccines have challenges to overcome.

Altimmune (NASDAQ:ALT) Earns Buy Rating from JMP Securities - Vimarsana News

Altimmune (NASDAQ:ALT) Earns Buy Rating from JMP Securities

Altimmune (NASDAQ:ALT – Get Rating)‘s stock had its “buy” rating reiterated by research analysts at JMP Securities in a research report issued on Wednesday, TipRanks reports. They currently have a $22.00 price target on the stock. JMP Securities’ price target suggests a potential upside of 339.12% from the company’s previous close. Other analysts also recently […]

Altimmune to Present at Upcoming Investor Conferences - Vimarsana News

Altimmune to Present at Upcoming Investor Conferences

GAITHERSBURG, Md., May 16, 2022 -- Altimmune, Inc. , a clinical-stage biopharmaceutical company, today announced that members of the Company’s management team will participate at the... | May 16, 2022

Guggenheim Lowers Altimmune (NASDAQ:ALT) Price Target to $27.00 - Vimarsana News

Guggenheim Lowers Altimmune (NASDAQ:ALT) Price Target to $27.00

Altimmune (NASDAQ:ALT – Get Rating) had its price target lowered by equities research analysts at Guggenheim to $27.00 in a research report issued on Monday, Stock Target Advisor reports. The firm presently has a “na” rating on the stock. Guggenheim’s price target points to a potential upside of 461.33% from the company’s current price. Other […]

Analysts Anticipate Altimmune, Inc. (NASDAQ:ALT) to Announce -$0.57 Earnings Per Share - Vimarsana News

Analysts Anticipate Altimmune, Inc. (NASDAQ:ALT) to Announce -$0.57 Earnings Per Share

Wall Street analysts forecast that Altimmune, Inc. (NASDAQ:ALT – Get Rating) will announce earnings of ($0.57) per share for the current quarter, according to Zacks. Three analysts have made estimates for Altimmune’s earnings, with the highest EPS estimate coming in at ($0.43) and the lowest estimate coming in at ($0.70). Altimmune posted earnings of ($0.38) […]